Correlation Between Medigen Biotechnology and International CSRC

Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and International CSRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and International CSRC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Biotechnology and International CSRC Investment, you can compare the effects of market volatilities on Medigen Biotechnology and International CSRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of International CSRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and International CSRC.

Diversification Opportunities for Medigen Biotechnology and International CSRC

0.59

Correlation Coefficient

Medigen Biotechnology  International CSRC

Very weak diversification

The 3 months correlation between Medigen and International is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and International CSRC Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International CSRC and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with International CSRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International CSRC has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and International CSRC go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and International CSRC

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the International CSRC. In addition to that, Medigen Biotechnology is 1.56 times more volatile than International CSRC Investment. It trades about -0.06 of its total potential returns per unit of risk. International CSRC Investment is currently generating about -0.07 per unit of volatility. If you would invest  1,600  in International CSRC Investment on September 3, 2024 and sell it today you would lose (80.00) from holding International CSRC Investment or give up 5.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Medigen Biotechnology  vs.  International CSRC Investment

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

International CSRC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days International CSRC Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, International CSRC is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Medigen Biotechnology and International CSRC

The main advantage of trading using opposite Medigen Biotechnology and International CSRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, International CSRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International CSRC will offset losses from the drop in International CSRC's long position.

The idea behind Medigen Biotechnology and International CSRC Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.